LRMR (Larimar Therapeutics) Insider Ownership: 1.41 % (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LRMR Larimar Therapeutics Inc LRMR
35 GF Score
Price $4.32
! 2 Warning Signs
View Full Analysis

What is Larimar Therapeutics Insider Ownership?

Larimar Therapeutics LRMR +0.23% 35 Insider Ownership is 1.41 % as of Aug. 12, 2026. GuruFocus rates LRMR with a GF Score™ of 35/100. The stock has 2 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Larimar Therapeutics's insider ownership is 1.41%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Larimar Therapeutics's Institutional Ownership is 84.95%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Larimar Therapeutics's Float Percentage Of Total Shares Outstanding is 64.74%.

Larimar Therapeutics Insider Ownership Historical Data

* Premium members only.

The historical data trend for Larimar Therapeutics's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Larimar Therapeutics Insider Ownership Chart

Larimar Therapeutics Historical Data

The historical data trend for Larimar Therapeutics can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 1.92 1.44 1.44 1.44 1.44 1.57 1.23 1.36 1.36 1.41
LRMR
35GF Score
Larimar Therapeutics Inc LRMR
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Larimar Therapeutics Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 1.41 % mean?
Larimar Therapeutics (LRMR) has a Insider Ownership of 1.41 % as of Aug. 12, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Larimar Therapeutics and its competitors.
Is Larimar Therapeutics' Insider Ownership too high?
Larimar Therapeutics' current Insider Ownership is 1.41 %. Overall, Larimar Therapeutics has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Larimar Therapeutics' Insider Ownership compare to OCGN and EVMN?
Larimar Therapeutics' Insider Ownership of 1.41 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Larimar Therapeutics and its competitors. Larimar Therapeutics's current Insider Ownership is 1.41 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Larimar Therapeutics stock overvalued right now?
Larimar Therapeutics (LRMR) has a current Insider Ownership of 1.41 %. The current Insider Ownership is 1.41 %. Larimar Therapeutics' overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Larimar Therapeutics (LRMR), the current Insider Ownership is 1.41 % as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Larimar Therapeutics Business Description

Other Exchanges ZA71:Germany
Address Three Bala Plaza East, Suite 506, Bala Cynwyd, PA, USA, 19004
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate, nomlabofusp, is a subcutaneously administered recombinant fusion protein designed to deliver frataxin (FXN) to the mitochondria of patients with Friedreich's ataxia (FA), a rare genetic disease characterized by insufficient production of FXN. The company also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.
35GF Score

Get the complete analysis for LRMR

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.32
Price